Recognition of a Kawasaki disease shock syndrome

Pediatrics

Volumn 123, Issue 5, 2009, Pages

  Kanegaye, John T ^a,c   Wilder, Matthew S ^a   Molkara, Delaram ^a,c   Frazer, Jeffrey R ^a,c   Pancheri, Joan ^c   Tremoulet, Adriana H ^a,c   Watson, Virginia E ^a   Best, Brookie M ^a,b   Burns, Jane C ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Echocardiography; Kawasaki disease (mucocutaneous lymph node syndrome); Shock; Ventricular function

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; D DIMER; DOBUTAMINE; DOPAMINE; FIBRINOGEN; HEMOGLOBIN; IMMUNOGLOBULIN; MILRINONE; NORADRENALIN; PROTHROMBIN; VASOACTIVE AGENT;

ACUTE DISEASE; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY; CORONARY ARTERY DISEASE; DATA COLLECTION METHOD; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; FLUID RESUSCITATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE COMPLIANCE; HEART MUSCLE RELAXATION; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INFANT; KAWASAKI DISEASE SHOCK SYNDROME; LABORATORY TEST; MALE; MITRAL VALVE REGURGITATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SHOCK; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; CRITICAL CARE; FEMALE; HUMANS; HYPOTENSION; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 66049158943     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1871     Document Type: Article

References (27)

1. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379-1385 (Pubitemid 26307269)
2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747-2771 (Pubitemid 39453026)
3. Ralston M, Hazinski MF, Zaritsky AL, Schexnayder SM, Kleinman ME. Pediatric Advanced Life Support Provider Manual. Dallas, TX: American Heart Association; 2006
4. Dieckmann RA. Pediatric assessment. In: Gausche-Hill M, Fuchs S, Yamamoto L, eds. APLS: The Pediatric Emergency Medicine Resource. 4th ed. Sudbury, MA: Jones and Bartlett; 2007: 20-51
5. Fitzmaurice L, Gerardi MJ. Cardiovascular system. In: Gausche-Hill M, Fuchs S, Yamamoto L, eds. APLS: The Pediatric Emergency Medicine Resource. 4th ed. Sudbury, MA: Jones and Bartlett; 2007:106-145
6. Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153(1):117-121
7. McCrindle BW, Li JS, Minich LL, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116(2):174-179 (Pubitemid 47057523)
8. Kimball TR, Michelfelder EC. Echocardiography. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, eds. Moss and Adams' Heart Disease in Infants, Children and Adolescents: Including the Fetus and Young Adult. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:95-163
9. Schmitz L, Xanthopoulos A, Koch H, Lange PE. Doppler flow parameters of left ventricular filling in infants: how long does it take for the maturation of the diastolic function in a normal left ventricle to occur? Pediatr Cardiol. 2004;25(5):482-491 (Pubitemid 39382814)
10. Eidem BW, McMahon CJ, Cohen RR, et al. Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. J Am Soc Echocardiogr. 2004;17(3):212-221 (Pubitemid 38879250)
11. Schmitz L, Koch H, Bein G, Brockmeier K. Left ventricular diastolic function in infants, children, and adolescents: reference values and analysis of morphologic and physiologic determinants of echocardiographic Doppler flow signals during growth and maturation. J Am Coll Cardiol. 1998;32(5):1441-1448 (Pubitemid 28522407)
12. Burns JC, Glode MP, Clarke SH, Wiggins J, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. J Pediatr. 1984;105(2):206-211 (Pubitemid 14060207)
13. Palmer AL, Walker T, Smith JC. Acute respiratory distress syndrome in a child with Kawasaki disease. South Med J. 2005;98(10):1031-1033 (Pubitemid 41572208)
14. Fuse S, Tomita H, Ohara T, Iida K, Takamuro M. Severely damaged aortic valve and cardiogenic shock in an infant with Kawasaki disease. Pediatr Int. 2003;45(1):110-113 (Pubitemid 36523573)
15. Senzaki H, Suda M, Noma S, Kawaguchi H, Sakakihara Y, Hishi T. Acute heart failure and acute renal failure in Kawasaki disease. Acta Paediatr Jpn. 1994;36(4):443-447 (Pubitemid 24259217)
16. Case records of the Massachusetts General Hospital: case 36-1998: an 11-year-old girl with fever, hypotension, and azotemia. N Engl J Med. 1998;339(22):1619-1626
17. Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics. 2008;122(4). Available at: www.pediatrics.org/cgi/content/full/122/ 4/e786
18. Goldstein B, Giroir B, Randolph A; Members of the International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2-8
19. Goldstein B, Giroir B, Randolph A. Values for systolic blood pressure. Pediatr Crit Care Med. 2005;6(4):500-501 (Pubitemid 40980843)
20. Haque IU, Zaritsky AL. Analysis of the evidence for the lower limit of systolic and mean arterial pressure in children. Pediatr Crit Care Med. 2007;8(2):138-144 (Pubitemid 46568563)
21. Dickinson R, Singer AJ, Carrion W. Etomidate for pediatric sedation prior to fracture reduction. Acad Emerg Med. 2001;8(1):74-77 (Pubitemid 32057935)
22. Sharieff GQ, Trocinski DR, Kanegaye JT, Fisher B, Harley JR. Ketamine-propofol combination sedation for fracture reduction in the pediatric emergency department. Pediatr Emerg Care. 2007;23(12):881-884 (Pubitemid 350307360)
23. Barbi E, Marchetti F, Gerarduzzi T, et al. Pretreatment with intravenous ketamine reduces propofol injection pain. Paediatr Anaesth. 2003;13(9):764-768 (Pubitemid 37475875)
24. Kaabachi O, Chettaoui O, Ouezini R, Abdelaziz AB, Cherif R, Kokki H. A ketamine-propofol admixture does not reduce the pain on injection compared with a lidocaine-propofol admixture. Paediatr Anaesth. 2007;17(8):734-737 (Pubitemid 47000666)
25. Tosun Z, Esmaoglu A, Coruh A. Propofol-ketamine vs propofol-fentanyl combinations for deep sedation and analgesia in pediatric patients undergoing burn dressing changes. Paediatr Anaesth. 2008;18(1):43-47 (Pubitemid 350264603)
26. Zuckerbraun NS, Pitetti R, Herr SM, Roth KR, Gaines BA, King C. Use of etomidate as an induction agent for rapid sequence intubation in a pediatric emergency department. Acad Emerg Med. 2006;13(6):602-609 (Pubitemid 43744545)
27. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report: second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006;47(4):373-380 (Pubitemid 43190153)